NEUROPHET Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-23,297	-22,389	-15,101
Depreciation & Amortization	1,126	1,110	1,095
Loss (Gain) From Sale of Assets	0.2	0.08	3.48
Stock-Based Compensation	594.62	591.83	552.27
Provision & Write-off of Bad Debts	362.9	347.3	0.13
Other Operating Activities	5,694	5,962	942.32
Change in Accounts Receivable	-202.31	-172.55	-144.57
Change in Inventory	-27.13	-20.59	13.08
Change in Other Net Operating Assets	39.47	-496.55	26.95
Operating Cash Flow	-15,708	-15,067	-12,613
Capital Expenditures	-571.39	-265.46	-248.74
Sale of Property, Plant & Equipment	0.28	0.51	6.86
Sale (Purchase) of Intangibles	-59.52	-59.47	-143.25
Investment in Securities	-9,100	-16,100	9,000
Other Investing Activities	16.1	66.93	3
Investing Cash Flow	-9,715	-16,357	8,618
Long-Term Debt Issued	-	5,000	-
Long-Term Debt Repaid	-	-625.6	-655.84
Net Debt Issued (Repaid)	-640.57	4,374	-655.84
Issuance of Common Stock	28,371	28,141	-
Financing Cash Flow	27,731	32,516	342.21
Foreign Exchange Rate Adjustments	12.71	-7.23	0.92
Net Cash Flow	2,321	1,084	-3,652
Free Cash Flow	-16,279	-15,332	-12,862
Free Cash Flow Margin	-635.32%	-586.30%	-580.35%
Free Cash Flow Per Share	-1473.79	-1576.25	-3484.24
Cash Interest Paid	41.87	48.52	0
Cash Income Tax Paid	-	-52.13	49.81
Levered Free Cash Flow	-	-39,964	-
Unlevered Free Cash Flow	-	-39,389	-
Change in Working Capital	-189.97	-689.69	-104.55